BioAtla, Inc.
NASDAQ:BCAB
0.4298 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 49.046 | 111.471 | 215.507 | 244.979 | 238.605 | 3.704 | 10.863 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 49.046 | 111.471 | 215.507 | 244.979 | 238.605 | 3.704 | 10.863 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.447 | 4.935 | 4.924 | 2.313 | 2.076 | 0.803 | 1.799 |
| Total Current Assets
| 51.232 | 116.406 | 220.431 | 247.292 | 240.681 | 4.507 | 12.662 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 1.19 | 3.098 | 5.151 | 6.976 | 4.102 | 4.675 | 3.878 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0.154 | 0.154 | 0.154 | 0.154 | 0.154 | 0.097 |
| Total Non-Current Assets
| 1.19 | 3.252 | 5.305 | 7.13 | 4.256 | 4.829 | 3.975 |
| Total Assets
| 52.422 | 119.658 | 225.736 | 254.422 | 244.937 | 9.336 | 16.637 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 1.902 | 3.819 | 4.231 | 1.179 | 2.456 | 5.139 | 1.961 |
| Short Term Debt
| 0.836 | 1.624 | 3.042 | 2.778 | 0 | 9.706 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 19.806 | 1.42 | 0.169 |
| Other Current Liabilities
| 11.802 | 22.901 | 15.858 | 15.856 | 9.999 | 10.453 | 7.066 |
| Total Current Liabilities
| 14.54 | 28.344 | 23.131 | 19.813 | 32.261 | 26.718 | 9.196 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 0.836 | 4.92 | 7.964 | 0.682 | 8.414 | 10.414 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 18.815 | 0.309 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 2.808 | 4.586 |
| Other Non-Current Liabilities
| 23.617 | 19.806 | 17.346 | 15.824 | 2.02 | 8.592 | 15.992 |
| Total Non-Current Liabilities
| 23.617 | 20.642 | 22.266 | 23.788 | 2.702 | 38.629 | 35.887 |
| Total Liabilities
| 38.157 | 48.986 | 45.397 | 43.601 | 34.963 | 65.347 | 45.083 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 89.345 | 89.345 |
| Common Stock
| 0.006 | 0.005 | 0.005 | 0.004 | 0.003 | 0.75 | 0.75 |
| Retained Earnings
| -486.039 | -416.263 | -292.801 | -186.319 | -90.917 | -148.354 | -118.56 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0 | 0 | -0 | 0 | 0 | -1.38 |
| Other Total Stockholders Equity
| 500.298 | 486.93 | 473.135 | 397.136 | 300.888 | 2.295 | 0 |
| Total Shareholders Equity
| 14.265 | 70.672 | 180.339 | 210.821 | 209.974 | -55.964 | -28.465 |
| Total Equity
| 14.265 | 70.672 | 180.339 | 210.821 | 209.974 | -56.011 | -28.446 |
| Total Liabilities & Shareholders Equity
| 52.422 | 119.658 | 225.736 | 254.422 | 244.937 | 9.336 | 16.637 |